Correction: mTOR inhibition affects Yap1-β-catenin-induced hepatoblastoma growth and development

Oncotarget. 2019 Sep 24;10(54):5670. doi: 10.18632/oncotarget.27218.

Laura Molina^#^{1

2}, Hong Yang^#³, Adeola O Adebayo Michael⁴, Michael Oertel^{1

5}, Aaron Bell¹, Sucha Singh¹, Xin Chen⁶, Junyan Tao¹, Satdarshan P Monga^{1

5

7}

¹ Division of Experimental Pathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
² Medical Scientist Training Program, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
³ Department of Medical Ultrasonics, The First Affiliated Hospital of Guangxi Medical University, Guangxi, China.
⁴ Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USA.
⁵ Pittsburgh Liver Research Center, University of Pittsburgh Medical Center and University of Pittsburgh School of Medicine, Pittsburgh PA, USA.
⁶ Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, CA, USA.
⁷ Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

^# Contributed equally.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.26668.].